PetMed Express, Inc. reports results for the quarter ended September 30 - Earnings Summary

PetMed Express

Tue 22:40

PetMed Express, Inc. PETS.OQ reported a quarterly adjusted loss of 31 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -41 cents.  The lone analyst forecast for the quarter was for a loss of 6 cents per share. 
Revenue fell 19.4% to $35.77 million from a year ago. 
PetMed Express, Inc.'s reported EPS for the quarter was a loss of 31 cents​.
The company reported a quarterly loss of $6.43 million.
PetMed Express, Inc. shares had fallen by 9.4% this quarter and lost 60.9% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts was unchanged in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "sell" and the breakdown of recommendations is no "strong buy" or "buy," no "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the drug retailers peer group is  "buy."
Wall Street's median 12-month price target for PetMed Express, Inc. is $1.40, about 10.7% above its last closing price of $1.25
This summary was machine generated from LSEG data November 10 at 10:39 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Sep. 30 2026 
-0.06
-0.31
Missed
Jun. 30 2026 
0.12
-0.28
Missed
Mar. 31 2026 
-0.18
-0.19
Missed
Dec. 31 2025 
-0.06
-0.50
Missed